<DOC>
	<DOCNO>NCT00004099</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . It yet know surgery alone surgery combined chemotherapy effective treat stomach cancer . PURPOSE : Randomized phase III trial compare effectiveness surgery without combination chemotherapy treat patient stage II , stage III , stage IV stomach cancer .</brief_summary>
	<brief_title>Surgery With Without Combination Chemotherapy Treating Patients With Stomach Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall survival patient locally advanced gastric cancer treat surgery alone combination neoadjuvant cisplatin , leucovorin calcium fluorouracil . - Compare two regimen term rate complete resection , time progression , morbidity patient . - Evaluate toxicity disease response neoadjuvant chemotherapy patient . - Evaluate quality life performance status patient pre- post-surgery compare quality life regimen . OUTLINE : This randomize , open label , multicenter study . Patients stratify accord center , primary tumor category ( cT3 cT4 ) , localization tumor ( upper third include cardia II III v middle lower third ) , gender , histological subtype ( intestinal v nonintestinal ) . Patients randomize one two treatment arm . - Arm I : Patients receive cisplatin IV 1 hour day 1 , 15 , 29 . Patients also receive leucovorin calcium IV 2 hour follow fluorouracil IV 24 hour day 1 , 8 , 15 , 22 , 29 , 36 . A second course administer begin 2 week later absence disease progression unacceptable toxicity . Patients undergo resection lymphadenectomy day 57-63 second course chemotherapy . - Arm II : Patients undergo resection lymphadenectomy within 14 day randomization . Quality life assess randomization , every 3 month 1 year 2 year randomization . Patients follow every 3 month 1 year , every 6 month 2 year , every 3 month thereafter death . PROJECTED ACCRUAL : A total 360 patient ( 180 per arm ) accrue study 4 year .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Levoleucovorin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven stage IIIV adenocarcinoma stomach include cardia carcinoma type II III Locally resectable disease No distant metastases except M1 lymph nod No evidence peritoneal carcinomatosis Free tumor cell lavage laparoscopy allow No uncontrolled bleeding primary tumor No gastric outlet syndrome complete tumor stenosis would require total parenteral nutrition PATIENT CHARACTERISTICS : Age : 18 69 Performance status : WHO 01 Life expectancy : Not specify Hematopoietic : WBC great 4,000/mm^3 Absolute neutrophil count great 2,000/mm^3 Platelet count great 100,000/mm^3 Hepatic : Bilirubin great 1.25 time upper limit normal ( ULN ) Prothrombin rate least 70 % Renal : Creatinine great 1.25 time ULN Creatinine clearance great 60 mL/min Cardiovascular : No prior atrial ventricular arrhythmia No prior congestive heart failure No myocardial infarction within past 6 month Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No prior concurrent neoplasm except curatively treat nonmelanoma skin cancer carcinoma situ cervix No active infection No allergy protocol drug No dementia significantly alter mental status No serious medical condition would prevent compliance PRIOR CONCURRENT THERAPY : Biologic therapy : No filgrastim ( GCSF ) within 48 hour prior chemotherapy Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiotherapy Surgery : See Disease Characteristics No prior stent implantation No prior laser therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>69 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>stage II gastric cancer</keyword>
	<keyword>stage III gastric cancer</keyword>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>intestinal adenocarcinoma stomach</keyword>
	<keyword>diffuse adenocarcinoma stomach</keyword>
	<keyword>mixed adenocarcinoma stomach</keyword>
</DOC>